drugset / Trial / NCT02849184

To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia

NCT02849184

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the effectiveness and safety of suvorexant versus placebo on sleep pressure and circadian rhythm in hypertensives with insomnia.

Timeline

Start
2017-01-17
Primary completion
2017-10
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Suvorexant Small molecule 15 mg Oral
Subject Suvorexant Small molecule 20 mg Oral